NeurologyLive® Friday 5 — February 25, 2022

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 25, 2022.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: ACTRIMS Forum 2022

The NeurologyLive® team is providing live coverage from the Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2022, including on-site video interviews with experts and the latest clinical data readouts and presentations.

2: Mind Moments: Addressing Parkinson Disease Virtually With Prime PD

In Episode 58 of Mind Moments, a podcast from NeurologyLive®, brings you an exclusive interview with Konstantin Karmazin, MD, on the digital wellness studio, Prime PD, and its potential benefits for patients with Parkinson disease and their physicians.

3: NeuroVoices: Andrea Synowiec, DO, on Using a Large-Scale Data Registry to Capture Patient-Reported Outcomes

The assistant director of the Allegheny Headache Center provided context on a recently created headache registry, the need to prioritize treatment outcomes that matter to patients, and her belief that the holistic, patient-centric data the registry captures will help clinicians make more accurate treatment decisions.

4: Peers & Perspectives: Identifying and Evaluating Off-Episodes in Parkinson Disease

In episode 2 of this of NeurologyLive® Peers & Perspectives series, "Parkinson Disease: Managing Off-Episodes," Rajesh Pahwa, MD, and Cynthia Comella, MD, explain the challenges in identifying off-episodes and tactics they use to evaluate them.

5: Epstein-Barr Virus and MS: Exploring Implications From Bench to Bedside

Alberto Ascherio, MD, DrPH, and Lawrence Steinman, MD, join NeurologyLive in a conversation about the clinical and research implications of a causative relationship between Epstein-Barr virus and multiple sclerosis in this NeurologyLive® follow-up discussion.

—————————————————